New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 18, 2014
10:08 EDTCVSCVS Caremark sees 2014 share repurchases of $4B
CVS says that it is "well-positioned" for growth in a changing health care landscape. Says increased Medicaid enrollment will fuel its leading position in managed Medicaid. Sees 43M people enrolled in Medicaid enrollment by 2016. Says "well-positioned" to gain share in exchanges across the enterprise. Says overall growth in exchanges will be a net positive. Says focused on enhancing shareholder value through driving long-term growth, generating "significant" free cash flow and optimizing capital allocation. In terms of CAGR from FY13-FY18, CVS sees net revenue 9%-13%, sees operating profit 7%-9%, sees final adjusted EPS 10%-14%, sees share repurchase contribution 4%-6% and average annual cash available for enhancing shareholder value $7.5B-$8.5B. When discussing efficient cash deployment from FY14 through FY18, CVS says it will have $40B in cash available for enhancing shareholder value. Expects a target payout ratio for dividends during that time to be 35% by FY18 with 18% implied dividend CAGR. Expects a return on invested capital and says that it will drive ROIC with value-enhancing projects. Sees $4B-$5B of share repurchases per year through 2018. Comments taken from slides from CVS Caremark's presentation at the Wells Fargo Healthcare conference.
News For CVS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 28, 2015
08:31 EDTCVSCVS Health enters into clinical affiliations with two regional health systems
Subscribe for More Information
January 21, 2015
10:28 EDTCVSLeerink pharmaceuticals analyst holds an analyst/industry conference call
Subscribe for More Information
10:01 EDTCVSOn the Fly: Analyst Initiation Summary
Subscribe for More Information
10:01 EDTCVSOn the Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Ashford Hospitality (AHT) upgraded to Outperform from Neutral at Credit Suisse... BAE Systems (BAESY) upgraded to Buy from Neutral at Goldman... Bazaarvoice (BV) upgraded to Outperform from Market Perform at Cowen... Becton Dickinson (BDX) upgraded to Outperform at Cowen... CVS Health (CVS) upgraded to Buy from Neutral at Goldman... Camden Property (CPT) upgraded to Outperform from Neutral at Credit Suisse... ConocoPhillips (COP) upgraded to Buy from Neutral at BofA/Merrill... Cornerstone OnDemand (CSOD) upgraded to Buy from Neutral at DA Davidson... Cree (CREE) upgraded to Overweight at Stephens... DDR Corp. (DDR) upgraded to Outperform from Neutral at Credit Suisse... EastGroup Properties (EGP) upgraded to Outperform from Neutral at Credit Suisse... Energy Transfer Partners (ETP) upgraded to Outperform from Neutral at Credit Suisse... Esperion (ESPR) upgraded at BofA/Merrill... Exxon Mobil (XOM) upgraded to Outperform from Market Perform at Wells Fargo... FXCM (FXCM) upgraded to Market Perform from Underperform at Keefe Bruyette... Fair Isaac (FICO) upgraded to Overweight from Equal Weight at Barclays... Golar LNG (GLNG) upgraded to Buy from Hold at Nordea... Gran Tierra (GTE) upgraded to Buy at Canaccord... Host Hotels (HST) upgraded to Outperform from Neutral at Credit Suisse... J.M. Smucker (SJM) upgraded to Overweight from Neutral at JPMorgan... Kilroy Realty (KRC) upgraded to Neutral from Underperform at Credit Suisse... Level 3 (LVLT) upgraded to Outperform from Market Perform at Wells Fargo... Lowe's (LOW) upgraded to Overweight from Equal Weight at Morgan Stanley... Michael Kors (KORS) upgraded to Outperform at Cowen... Netflix (NFLX) upgraded at Nomura... Regions Financial (RF) upgraded to Buy from Neutral at Guggenheim... Ruckus Wireless (RKUS) upgraded to Outperform from Market Perform at Northland... Santander Mexico (BSMX) upgraded to Neutral from Underperform at Credit Suisse... Scorpio Tankers (STNG) upgraded to Buy at Canaccord... Sprouts Farmers Markets (SFM) upgraded to Buy from Neutral at BofA/Merrill... Strategic Hotels (BEE) upgraded to Outperform from Neutral at Credit Suisse... The Medicines Co. (MDCO) upgraded to Outperform from Market Perform at Leerink... Whole Foods (WFM) upgraded at Sterne Agee... Wolseley (WOSYY) upgraded to Neutral from Underperform at Exane BNP Paribas.
07:37 EDTCVSCVS Health initiated with an Overweight at Stephens
Subscribe for More Information
06:05 EDTCVSCVS Health upgraded to Buy from Neutral at Goldman
Goldman upgraded CVS to Buy based on strong leverage to Rx growth and Specialty, procurement savings upside, and capital deployment optionality. Price target raised to $113 from $95.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use